Evidence map›Paper›PMID 40027664›Full record

ArticlebioRxiv : the preprint server for biology2025

Click-Based Determination of Accumulation of Molecules in

George M Ongwae, Zichen Liu, Shasha Feng, Mahendra D Chordia, Mohammad Sharifian Gh, Rachita Dash, Brianna E Dalesandro, Taijie Guo, Karl Barry Sharpless, Jiajia Dong and 3 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

George M Ongwae
Zichen Liu
Shasha Feng
Mahendra D Chordia
Mohammad Sharifian Gh
Rachita Dash
Brianna E Dalesandro
Taijie Guo
Karl Barry Sharpless
Jiajia Dong
M Sloan Siegrist
Wonpil Im

Funding

Structural Determinants of Permeation Barriers in Escherichia coliR01AI178975 · NIAID · UNIVERSITY OF VIRGINIA · PI PIRES, MARCOS M. · 2023 to 2024
$1.2M
NIAID NIH HHS R01 AI178975
6 · The paper itself

Abstract

Gram-negative bacterial pathogens pose a significant challenge in drug development due to their outer membranes, which impede the permeation of small molecules. The lack of widely adoptable methods to measure the cytosolic accumulation of compounds in bacterial cells has hindered drug discovery efforts. To address this challenge, we developed the CHloroalkane Azide Membrane Permeability (CHAMP) assay, specifically designed to assess molecule accumulation in the cytosol of Gram-negative bacteria. The CHAMP analysis utilizes biorthogonal epitopes anchored within HaloTag-expressing bacteria and measures the cytosolic arrival of azide-bearing test molecules through strain-promoted azide-alkyne cycloaddition. This workflow allows for robust and rapid accumulation measurements of thousands of azide-tagged small molecules. Our approach consistently yields a large number of accumulation profiles, significantly exceeding the scale of previous measurements in

Identifiers

PMID40027664
PMCPMC11870406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.